AVBP

ArriVent BioPharma, Inc. $13.35 as of 2026-11-02
Model view — historical tendencies for the days ahead, not a forecast
Next 1 day
+1.3%
Next 1 week
+0.8%
Next 1 month
+2.1%
Seasonality
Not enough history
20-year seasonality chart →
Mean reversion
Deeply oversold — RSI(2) at 6
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought. Its dip-buy edge in history is +0.25%/day.
Mean-reversion stats →
1-month breakdown — Market · β 0.88 +2.1%
$44M/day volume 80% volatility -28% 1-year -63% from ATH
52-week range · 8% of the way up · -63% from the high
$11.36$35.83

Earnings Full history →

Next report 2026-11-16 (Monday, after close, in 13 days) · EPS est. -1.06.

1-day std dev
4.6%
Finished up
27%
Biggest pop
+3.1%
Biggest drop
-11.9%

Standard deviation of the close-to-close move over the last 11 reports. History, not a forecast.

ReportedEst.Actual SurpriseGap Day 1Day 5
2026-08-12 miss -0.98 -1.05 -6.7% -2.3% -4.6% -7.2%
2026-05-11 miss -0.89 -0.96 -7.4% -2.2% -0.2% -9.9%
2026-03-05 beat -0.85 -0.78 +7.7% +0.6% -7.2% -5.3%
2025-11-10 miss -0.78 -0.83 -6.0% +3.5% +3.1% +14.7%
2025-08-11 miss -0.71 -0.90 -26.5% +1.3% -3.3% +6.9%
2025-05-12 miss -0.69 -1.90 -175.4% +0.0% -0.8% -4.0%
2025-03-03 beat -0.78 -0.61 +21.9% -0.3% -6.7% -8.0%
2024-11-14 beat -1.07 -0.61 +42.8% -0.6% -11.9% -16.5%
2024-08-14 miss -0.59 -0.65 -10.5% +0.5% -0.4% -0.3%
2024-05-08 beat -1.30 -0.70 +46.0% -2.5% +0.6% +13.0%
2024-03-28 miss -0.65 -30.76 -4632.3% +0.3% +2.5% -2.1%

Not investment advice.